Get the Stockscreener App
3.22
0.94%
0.03
Orchestra Biomed Holdings Inc stock is traded at $3.22, with a volume of 81,832.
It is up +0.94% in the last 24 hours and up +0.00% over the past month.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
See More
Previous Close:
$3.19
Open:
$3.2
24h Volume:
81,832
Relative Volume:
0.17
Market Cap:
$123.37M
Revenue:
$2.76M
Net Income/Loss:
$-49.12M
P/E Ratio:
-2.1467
EPS:
-1.5
Net Cash Flow:
$-46.21M
1W Performance:
+1.58%
1M Performance:
+0.00%
6M Performance:
-39.59%
1Y Performance:
-59.75%
1-Day Range:
$3.05
$3.30
1-Week Range:
$3.0401
$3.30
52-Week Range:
$2.37
$8.30
Orchestra Biomed Holdings Inc Stock (OBIO) Company Profile
Name
Orchestra Biomed Holdings Inc
Sector
Industry
Phone
646-343-9298
Address
150 UNION SQUARE DRIVE, NEW HOPE
Compare OBIO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OBIO
Orchestra Biomed Holdings Inc
|
3.22 | 122.60M | 2.76M | -49.12M | -46.21M | -1.50 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.27 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.64 | 61.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.00 | 42.46B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.74 | 35.22B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
296.46 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Orchestra Biomed Holdings Inc Stock (OBIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-20-25 | Initiated | BTIG Research | Buy |
| Jan-02-25 | Initiated | Barclays | Overweight |
| Aug-22-24 | Initiated | H.C. Wainwright | Buy |
| Jul-25-24 | Initiated | B. Riley Securities | Buy |
| Jan-19-24 | Initiated | Jefferies | Buy |
| Feb-24-23 | Initiated | Piper Sandler | Overweight |
| Feb-07-23 | Initiated | Chardan Capital Markets | Buy |
View All
Orchestra Biomed Holdings Inc Stock (OBIO) Latest News
IFP Advisors Inc Acquires 83,481 Shares of Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World
Is Orchestra BioMed Holdings Inc. a good long term investmentPowerful growth strategies - Autocar Professional
What drives Orchestra BioMed Holdings Inc. stock priceFree Advanced Stock Screener Access - Autocar Professional
Orchestra BioMed Holdings Inc. Stock Analysis and ForecastBreakthrough stock performance - Autocar Professional
What analysts say about Orchestra BioMed Holdings Inc. stockRapid market gains - jammulinksnews.com
Why Orchestra BioMed Holdings Inc. stock attracts strong analyst attentionFree Predictions - Newser
How Orchestra BioMed Holdings Inc. stock performs during market volatilityDouble Your Capital Alerts - Newser
What makes Orchestra BioMed Holdings Inc. stock price move sharplyMinimized Risk Trading Plan - Newser
How To Trade (OBIO) - news.stocktradersdaily.com
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Given Consensus Rating of “Buy” by Brokerages - Defense World
Orchestra BioMed (NASDAQ:OBIO) Trading Up 1.7% – Here’s What Happened - Defense World
Orchestra BioMed Secures FDA Clearance for Virtue Trial to Advance Coronary ISR Treatment - MSN
Orchestra BioMed to Present at Jefferies Global Healthcare Conference - MSN
Hedge funds owners may take dramatic actions as Orchestra BioMed Holdings, Inc.'s (NASDAQ:OBIO) recent 14% drop adds to one-year losses - simplywall.st
Learn to Evaluate (OBIO) using the Charts - news.stocktradersdaily.com
Orchestra BioMed: A Contrarian Gem in the Biotech Doldrums - AInvest
Orchestra BioMed Holdings, Inc.(NasdaqGM:OBIO) dropped from Russell Small Cap Comp Value Index - MarketScreener
Orchestra BioMed Confirms Director Elections and Auditor - TipRanks
Orchestra BioMed Showcases AVIM Therapy as Purpose-Built - GlobeNewswire
Millennium Management LLC Makes New Investment in Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World
Citadel Advisors LLC Sells 7,836 Shares of Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World
(OBIO) Trading Advice - news.stocktradersdaily.com
Orchestra Biomed Reports Increased Losses Amid Revenue Growth - TipRanks
B. Riley Cuts Price Target on Orchestra BioMed Holdings to $12 From $15, Keeps Buy Rating - marketscreener.com
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Stake Increased by Northern Trust Corp - Defense World
Orchestra BioMed: Two Best-In-Class Devices And Promising Partnerships - Seeking Alpha
Orchestra BioMed Reports Q1 2025 Financial Results and Advances Key Clinical Programs - MSN
The Manufacturers Life Insurance Company Raises Position in Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World
FY2026 Earnings Estimate for OBIO Issued By Chardan Capital - Defense World
Orchestra Biomed Holdings Inc Stock (OBIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.32%
1.57%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):